Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Rising Pharma Holding, Inc. recalls buPROPion Hydrochloride Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of Foreign Tablets/Capsules
Products
  • buPROPion Hydrochloride Extended-Release Tablets
Where it was sold

Nationwide within the United States

Nationwide

Units affected
47,976 bottles
About this recall
buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03